Objective: Data regarding risks and consequences of acute kidney injury (AKI) after cardiac transplantation are dismissingly few and unclear. This study defined the incidence, risk factors and prognostic implication of AKI in a single-center cohort operated on between January 1999 and December 2008. Methods: Data from 307 consecutive recipients (mean age: 47.42 AE 13.58, 20.5% female, 18.9% diabetics, 19.5% with previous cardiac operations, 26.4% hospitalized, 78.4 AE 33.7 ml min À1 preoperative glomerular filtration rate (eGFR)) were analyzed using multivariable logistic regression modeling. AKI was defined according to RIFLE (Risk, Injury, and Failure; and Loss, and End-stage kidney disease) criteria. Results: RIFLE scores of I or F were detected in 14%, and continuous venovenous hemofiltration was needed in 6.1%. Risk factors for AKI were: previous cardiac operation (odds ratio (OR) 2.35; 95% confidence interval (CI), 1.11-4.9), blood transfusion (OR 1.08; 95% CI, 1.011-1.16), troponin I release >10 (OR 1.031; 95% CI, 1.001-1.064), length of ischemic time (OR 1.008; 95% CI, 1.011-1.16). Overall hospital mortality averaged 7.8% and overall 1-year mortality was 10.4%; both mortality rates increased with each RIFLE stratification (Normal 3.4%, RIFLE R = 7.1%; RIFLE I = 25.7%; and RIFLE F = 37.5% and Normal 5.6%, RIFLE R = 11.8%, RIFLE I = 25.7%, and RIFLE F = 37.5%, respectively). AKI proved independent predictors of both early and 1-year mortality. The burden of AKI significantly affected 1-year kidney function (D preoperative GFR À 1-year GFR in AKI vs no AKI = À25.872 AE 22.54 vs À7.968 AE 34.18, p = 0.015). Conclusions: AKI is a highly prevalent and prognostically important complication. Some of the risk factors for AKI identified may be modifiable. #
Introduction
The incidence of cardiac-surgery-associated acute kidney injury (AKI), based on a variety of historical definitions, ranges from 0.3% to 29.7%. The development of AKI, even when the injury is relatively modest, is associated with increased morbidity and mortality and resource use [1] . In contrast to non-transplantation settings, data regarding risks and consequences of AKI after cardiac transplantation are less clear [2] . AKI after solid-organ-transplantation setting seems to be associated with prolonged intensive care unit (ICU) stay, need for postoperative dialysis, infectious complications, acute rejection, and reduced patient survival [3] . As authoritatively pointed out, most of the available studies are underpowered and inconclusive and usually did not investigate the relationship between AKI and other serious postoperative complications [4] . To mitigate the burden of AKI, numerous interventions have been tested, but none has proved efficacious. In the absence of proven interventions, a reasonable strategy would be to identify modifiable risk factors for AKI in this setting. These modifiable risk factors might, in turn, serve as therapeutic targets for preventing AKI. Consequently, we undertook this retrospective observational study to examine the prognostic importance of modifiable risk factors for AKI after heart transplant.
Methods

Study setting and patient sample
The study was conducted at the Department of Cardiothoracic and Respiratory Sciences of the Second University of Naples located in an affiliated teaching hospital (V. Monaldi Hospital). At this institution, nearly 700 patients have cardiac surgery annually and are admitted to a dedicated 12-bed postoperative ICU. Information from these patients is collected on a daily basis using standardized case report forms; all clinical perioperative data (including demographics, laboratory tests, nature of surgery, blood product transfusions, re-exploration, postoperative complications, and lengths of stay in the ICU and in the hospital) are collected. Data are entered into a computerized database including 100 variables, which was programmed to accept only matching double-entry data falling within prespecified ranges. All queries are resolved by referring to the patients' original records [5] . The Universal Transplant Database has been similarly developed to prospectively collect data concerning the specific transplant process of care [6] . These two databases were merged to perform the present analysis. Out of 317 consecutive patients undergoing cardiac transplantation between January 1999 and December 2008, 307 patients, who survived the surgical procedure and were not on preoperative renal replacement therapy, constituted the study sample.
Study design and aims
This retrospective single-center cohort study aimed to determine predictors and clinical implications of cardiacsurgery-associated acute kidney injury (CSA-AKI) (>50% decrease in estimated glomerular filtration rate (eGFR) and/ or need for continuous venovenous hemofiltration, CVVH) after orthotopic heart transplantation. The study aimed also to define independent predictors of hospital and 1-year mortality.
Surgical and critical perioperative care
Donor and recipients were matched for ABO blood-type compatibility and size (generally within 20% of body weight). Prospective human leukocyte antigen (HLA) matching was not used, with the exception of recipients with high levels of panel-reactive anti-HLA antibodies (>20%), who underwent a prospective cross-match. Male donors <40 years of age and female donors <45 years of age met criteria as suitable donors, provided there was no evidence of pre-existing heart disease or impaired myocardial dysfunction by echocardiography. Older individuals also met criteria as suitable donors provided that coronary atherosclerotic lesions could be excluded, ideally by cardiac catheterization. Individuals with serologies positive for hepatitis B and hepatitis C were matched with very-high-risk recipients in the emergency setting or standard recipients with specific immune competence and underwent a close infectivology follow-up, according to the rules of the national quality control center (Centro Nazionale Trapianti). Donors with serologies positive for human immunodeficiency virus (HIV) or non-primary brain cancer were excluded. Donor hearts were procured with standard technique and the grafts were protected with 2 l of cold (4-8 8C) Celsior solution and topical saline slush. Excised grafts were then immersed in 1 l of cold Celsior solution and stored under ice in closed cardiac storage container for transportation [7] . All recipients underwent standard orthotopic transplantation using the biatrial technique described by Lower and Shumway. Principles of intraoperative and postoperative care along with details on immunosuppressive regimen are reported extensively elsewhere [5] [6] [7] [8] [9] . Notably, in the early postoperative phase, immunosuppressive therapy with calcineurin inhibitors was withheld until complete normalization of renal function. Patients were maintained on induction therapy and steroids in the meanwhile.
Baseline data and clinical outcomes
To classify preoperative and 1-year postoperative kidney function, the National Kidney Foundation Classification staging system was adopted [10] . The severity of chronic kidney disease (CKD) is described by six stages: the most severe three are defined by the Modification of Diet in Renal Disease-estimated glomerular filtration rate (MDRD-eGFR) value, and the first three also depend on whether there is other evidence of kidney disease (e.g., proteinuria): . For women, the product of this equation was multiplied by correction factor of 0.742 [11] . The classification for AKI by the Acute Dialysis Quality Initiative Workgroup was constructed [12] . This classification has been named RIFLE according to the severity of renal impairment. The standard defines three grades of severityrisk (class R), injury (class I) and failure (class F) -and two outcome classes -loss of kidney function (class L) and endstage kidney disease (class E). This classification system includes separate criteria for creatinine and urine output. A patient can fulfill the criteria through changes in serum creatinine, eGFR or urine output: the criterion that leads to the worst possible classification should be used. RIFLE scoring is as follows:
(1) class R is considered if there is a 1.5-fold increase of serum creatinine or GFR decrease >25% or an urinary output <0.5 ml kg À1 h À1 for 6 h; (2) class I is considered if there is a twofold increase in serum creatinine, GFR decrease >50% or an urinary output <0.5 ml kg À1 h À1 for 12 h; and (3) class F is considered if there is a threefold increase of serum creatinine, GFR decrease >75%, or in patients with serum creatinine >4 mg dl À1 if there is an acute rise in serum creatinine of at least 0.5 mg dl À1 , or a urinary output <0.3 ml kg À1 h À1 for 24 h, or anuria for 12 h À1 .
The main parameters considered in this study for AKI definition were creatinine and GFR, due to the heterogeneity of volemia status and diuretic use in the study patients, affecting the relationship between renal status and urine output.
Definitions of graft failure, multiple organ failure, graft rejection, and infection strictly adhere to current released guidelines and are reported elsewhere [5] [6] [7] [8] [9] . Fatality (hospital mortality) was defined as all deaths occurring during the hospital period in which the operation was performed and those deaths occurring after hospital discharge but within 30 days of the procedure.
Statistical analysis
Data are expressed as mean AE SD for continuous variables and as percentages for categorical variables. Univariate parametric or non-parametric tests (chi-square Pearson test, unpaired Student's t-test, and Mann-Whitney test) and were first appropriately executed to address the clinical and statistical relevance of variables on the primary end point: factors with values of p 0.10 on univariate tests were included in the multivariable model. Multiple logistic regression was conducted using the forward stepwise method. As the series included patients operated on over a decade, changes in the pattern of perioperative care may have occurred. To account for such changes, date of operation was forced into the multivariable models. All statistical analyses were performed with Statistical Package for Social Sciences (SPSS) 10.0 (SPSS Inc., Chicago, IL, USA). Tables 1 and 2 summarize main recipients, donors, and transplants characteristics. Table 3 reports post-transplant outcomes including incidence of AKI (14%, n = 43 patients), need for renal replacement therapy along with hospital, and 1-year mortality rates.
Results
Study samples features
Incidence of AKI and its clinical implications
RIFLE scoring was: Normal 58.3%, Risk 27.7%, Injury 11.4% and Failure 2.6%. Higher RIFLE scores implied significant increase in unadjusted hospital mortality rates (score N, hospital mortality 3.4%; score R, 7.1% (relative risk (RR): 2.1); score I, 25.7% (RR: 7.6); and score F, 37.5% (RR: 11), respectively; p < 0.00001). Table 4 reports morbidity and mortality related with AKI. The latter was associated with graft failure and multi-organ failure, significantly prolonged each step of the process of care and implied worse in-hospital and 1-year mortality. AKI occurrence implied a significantly worse prognosis in patients with more compromised preoperative renal function (Fig. 1) . Heart transplant per se implied a significant worsening of renal function at 1 year (overall preoperative eGFR: 78.39 AE 33.78, overall 1-year As demonstrated by CKD staging before and after the procedure and the decrement in eGFR, AKI played a significant additive role in such a worsening (Fig. 2) .
Multivariable regression modeling for mortality rates and AKI
Univariate predictors of AKI were: previous cardiac surgery, mechanical circulatory support, ischemic time, extracorporeal circulation (ECC) length, troponin I release >10 mg l À1 , and transfusion of >4 blood units. Univariate predictors for hospital mortality were preoperative eGFR, AKI, RIFLE scoring, non-idiopathic cardiomyopathy, previous cardiac operation, early graft failure, and transfusion of >4 blood units. Univariate predictors of 1-year mortality were: preoperative eGFR, AKI, RIFLE scoring, non-idiopathic cardiomyopathy, previous cardiac operation, ischemic time, early graft failure, infection, and transfusion of >4 blood units. Multivariable logistic regression analysis for such outcomes is summarized in Table 5 . Independent predictors of AKI were several features of the surgical procedure (graft ischemic time, troponin release <10 mg l
À1
, previous cardiac operation, and transfusion of >4 blood units). Prognosticators of hospital mortality were AKI, previous cardiac operation, and graft failure. Preoperative eGFR exerted a protective effect. Determinants of 1-year mortality were AKI, serious infections, and graft failure. Preoperative eGFR exerted a protective effect also on 1-year survival. 
Discussion
In the present single-center cohort, AKI was a highly prevalent and prognostically important complication. Indeed, in the overall study sample, a reduction of eGFR !50% was detected in up to 14% of the patients and the need for renal replacement therapy in 6.1%. AKI developed in the context of other serious co-morbidity, such as primary graft failure and multiple organ failure and implied significant resource use and lengthening of the process of care. Occurrence of AKI exacerbated the loss of kidney function associated with the whole heart transplant process of care. It implied higher mortality in patients with more compromised preoperative kidney function and the most marked functional decrease in those with nearly normal preoperative renal function. Such findings are in good accord with major contemporary series [2] [3] [4] . Even milder reductions of eGFR were associated with death rates and multivariate regression modeling revealed that AKI independently predicted survival up to 1 year.
The RIFLE criteria were recently developed to standardize the diagnosis of acute renal failure and, in the process, the term 'acute kidney injury (AKI)' has been proposed to encompass the entire spectrum of the syndrome from minor changes in renal function to requirement for renal replacement therapy. Thus, AKI is not simply acute renal failure but a more general description. Indeed, small changes in kidney function in cardiac surgery patients are important and significantly affect short-and possibly long-term outcomes [13] . The RIFLE criteria have been already adopted in cardiac surgery populations and present study, for the first time, validates its use in outcome evaluation for heart transplant [14] .
To mitigate the burden of AKI after cardiac surgery, numerous interventions have been tested, but none has proved effective. In the absence of proven interventions, a reasonable strategy would be to identify modifiable risk factors for AKI in this setting [15] . Regression modeling for AKI disclosed the predictive role of graft ischemic time, troponin I release >10 mg l À1 , transfusion of >4 blood units, and previous cardiac operation.
Graft ischemic time and troponin release are known predictors of poor early graft performance. Critical shortage of heart grafts supply forces the evaluation of 'marginal' and distant donors. Effects of prolonged ischemic time on survival are dependent on donor age, with greater tolerance among grafts retrieved from younger donors [16] . Two recent studies have further evaluated the impact of prolonged ischemia on early postoperative morbidity [17, 18] . Both groups concluded that there is a significant increase in resource use to ensure recipients of distant grafts survive the early postoperative period. Indeed, incidence of primary graft failure, need for mechanical support, and acute renal failure proved higher [17, 18] . Authors concluded that, given that usage of distant donors is unavoidable, heart transplant centers will be increasingly more committed to better manage those receiving such grafts and to evaluate the cost-effectiveness of alternative strategies to best support patients with their condition worsening being on the waiting list. Intriguingly, the former conclusion strictly mirrors on one side, the evidence that management of primary graft failure is still developing and largely unsatisfactory, and, on the other, the newly generated evidence that effective renal preservation in high-risk surgical settings is based on optimization of perioperative hemodynamic performance [12, 19, 20] .
As far as troponin release after graft procurement is concerned, its impact on postoperative AKI has been also reported by a recent study by the Helsinki University Hospital [21] . Such a release is a well-recognized biochemical marker of preservation effectiveness [22] . Effectiveness of preservation largely relies on surgical procedure, type of cardioplegic solution, and the quality of graft itself, given an intrinsic higher vulnerability for those either hypertrophic, or older, or with unavailable coronary angiograms in presence of multiple risk factors and, of course, the distant ones. Such a pattern deserves three different considerations. First, as authoritatively reported, most of the surgical publications on prolonged cardiac preservation continue to result from small animal models of ex vivo ischemia and reperfusion with small impact on clinical practice; second, newly preservation strategies, based upon assisted beatingheart transportation, are in a nascent stage [23, 24] , and third, improvements in preharvesting graft management and functional and anatomical evaluation are still dismal.
There are convincing reports that red blood cells' (RBCs) transfusion to various subgroups of critically ill patients is associated with poorer outcomes. Transfusion of RBCs is increasingly recognized as a risk factor for adverse outcome 19 .5% of the cases. The finding that transfusion of >4 blood units but no other parameter of oxygen delivery adequacy during the perioperative phase emerged as AKI predictor after the regression modeling does not imply a causal relationship. Besides, blood transfusion did not emerge as independent predictor of survival. Indeed, in the view of the preoperative features of the population, namely a heart failure population with a considerable degree of advanced preoperative renal dysfunction, it should be considered a marker of risk.
Study overview
Several study limitations should be considered for a thorough data interpretation. First, the single-center setting, though guarantee of a uniform process of care, closely reflects the influence of specific standards of clinical practice and a unique patient population that may have led to results not readily transferable to other patient populations. On the other side, correctness of statistical tools in balancing for confounders make results of this analysis, of an unselected consecutive series of patients experiencing almost all clinically relevant events, transferable. Second, the observational design intrinsically prevents definition of causality, allowing just the disclosure of association between clinical factors. Third, given the retrospective design, it is possible that certain risk factors with a potential to influence AKI may have not been included in the database. Nevertheless, the data set included all major and clinical relevant prognosticators that, based on our clinical practice and on critical literature review, may influence kidney performance. Fourth, the series includes patients operated on during nearly a decade and it is possible that patterns of referral and perioperative care may have changed. Nevertheless, timing of surgery never showed up as an outcome predictors (see discussions on statistical analysis and results). Fifth, information regarding the cause and chronicity of kidney disease was not always available in the database. However, the number of patients with severe pre-existing kidney disease was relatively small and the large majority of them were long-time waiters with known medical history. Sixth, the analysis did not include data on dosages of immunosuppressive regimens, but definition of predictors on 1-year kidney function was beyond the scope of this study, and type of calcineurin inhibitor did not prove a predictor of both hospital and 1-year mortality. Finally, results of survival analyses may be influenced by the small number of target events. Nevertheless, the determinants disclosed are perfectly in accordance with those reported in the literature.
Conclusions
To the best of our knowledge, this is the first time that the RIFLE scoring system is evaluated in the heart transplant setting. Occurrence of AKI, even in milder degree, is prognostically important. Several surgical factors have been disclosed as independent predictors of AKI. Some of them may be used for preoperative risk stratification and may be amenable to modification. In this respect, the findings of this study, together with those forwarded by the literature, argue for a redefinition of current allocation protocols and a judicious evaluation of distant heart grafts. Several variables, such as donor age and stability, inotropic use, and leftventricular morphology and function should be factored besides the length of ischemic time in the decision of whether to accept or reject a given donor heart. Route of transportation (learjet and helicopter vs car) and beatingheart procurement should be maximized as well. Donor/ recipient matching should similarly take into account the global burden of distant/marginal heart procurement in the setting of more complex surgical procedures. Global heart failure management and in particular mechanical circulatory support should also be implemented to avoid worsening of preoperative status to an extent that urgent transplantation and donor/recipient matching are no more based on a thorough clinical judgment but on a last chance issue.
